NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
163 hedge funds and large institutions have $1.55B invested in NxStage Medical Inc. in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 64 increasing their positions, 61 reducing their positions, and 27 closing their positions.
161% more call options, than puts
Call options by funds: $3.22M | Put options by funds: $1.23M
5% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 61
5% less funds holding
Funds holding: 171 → 163 (-8)
8% less capital invested
Capital invested by funds: $1.68B → $1.55B (-$128M)
30% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 27
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$58.9M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$40.3M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$16.3M |
| 4 |
Millennium Management
New York
|
+$14.6M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$13.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$68.2M |
| 2 |
Jennison Associates
New York
|
-$14.9M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
-$14.5M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$14.5M |
| 5 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$11M |
NXTM Hedge Fund Activity: Q2 2017 in Review
163 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q2 2017, worth a combined $1.55B — down 7.7% from $1.68B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of NXTM and 19 opened new positions — a net loss of 8 holders — while 61 trimmed existing stakes and 64 added.
The largest buyer was Fidelity Investments, adding an estimated $58.9M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $68.2M.
- 163 institutional investors held NxStage Medical Inc. (NXTM) as of Q2 2017, down from 171 in Q1 2017.
- Funds reported $1.55B of NxStage Medical Inc. stock for Q2 2017, down 7.7% quarter-over-quarter.
- 19 funds opened new NxStage Medical Inc. positions in Q2 2017 and 27 closed out, a net change of -8 holders.
- The largest NxStage Medical Inc. buyer in Q2 2017 was Fidelity Investments, an estimated $58.9M added.
- The largest NxStage Medical Inc. seller in Q2 2017 was Gilder Gagnon Howe & Co, an estimated $68.2M sold.
Based on aggregated 13F filings for Q2 2017.